Avelumab for People With Recurrent Respiratory Papillomatosis

Conditions:   Recurrent Respiratory Papillomatosis;   Juvenile Laryngeal Papilloma;   Laryngeal Papilloma, Recurrent;   Respiratory Papillomatosis;   Human Papilloma Virus Intervention:   Drug: Avelumab Sponsor:   National Cancer Institute (NCI) Recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials